OmniAb, Inc. Common Stock
Veridion Score
BETALOW CONF · 6/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is OABI moving today?
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
OABI overview
Related filings and maps
Congress activity in OABI
No receipt-qualified Congressional disclosure is present for OABI in the cached public ledger.
OABI contract awards, year to date.
Public federal awards linked to this ticker.
OABI lobbying filings, year to date.
Registered lobbying filings matched to OmniAb, Inc. Common Stock.